cas 1808094-07-6|| where to buy N-(2-cyclobutyltriazol-4-yl)-2-[2-(3-methoxyphenyl)acetyl]-1,3-dihydroisoindole-5-sulfonamide

Nombre del producto:N-(2-cyclobutyltriazol-4-yl)-2-[2-(3-methoxyphenyl)acetyl]-1,3-dihydroisoindole-5-sulfonamide

IUPAC Name:N-(2-cyclobutyl-2H-1,2,3-triazol-4-yl)-2-[2-(3-methoxyphenyl)acetyl]-2,3-dihydro-1H-isoindole-5-sulfonamide

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1808094-07-6 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1808094-07-6; Fórmula molecular:C23H25N5O4S; Punto de fusión:-; Código de sonrisas:COC1=CC=CC(CC(=O)N2CC3=CC=C(C=C3C2)S(=O)(=O)NC2=NN(N=C2)C2CCC2)=C1; Densidad:

: Número de catálogo:CM775022; Peso molecular:467.54; Punto de ebullición:; Nº Mdl:MFCD31657365; Almacenamiento:

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.